Skip to main content
Clinical Trials/NCT07270445
NCT07270445
Recruiting
Not Applicable

Effect of Virtual Reality Use on Preoperative Anxiety: A Prospective, Randomized, Controlled Interventional Study (VeRA-Study)

Vera Guttenthaler1 site in 1 country172 target enrollmentStarted: January 28, 2026Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Vera Guttenthaler
Enrollment
172
Locations
1
Primary Endpoint
The change of anxiety

Overview

Brief Summary

The aim of this study is to investigate the effect of a non-pharmacological intervention-the use of a virtual reality headset-on preoperative anxiety levels in patients. For this purpose, both psychometric instruments (STOA and APAIS questionnaires) and objective physiological and EEG parameters are used. Patients who do not receive any additional intervention will form the control group.

The study was designed as a prospective, randomized, controlled, interventional study at the University Hospital Bonn. Patients aged 18 years and older who are scheduled to undergo elective surgery and who have no visual, hearing, or language impairments will be included in the study.

The primary objective of the study is the reduction of preoperative anxiety. The hypothesis is that preoperative use of the VR headset reduces perioperative anxiety, stress, and pain.

Detailed Description

The investigators are planning a prospective, randomized controlled study with the aim of reducing patients' preoperative anxiety through VR use and improving postoperative pain and anxiety levels. After obtaining informed consent, patients will be randomly assigned to either the control or the intervention group. Stratification will be performed based on the presence of relatives during the preoperative process (yes/no) to ensure an even distribution of this potential confounding factor.

Patient anxiety will be assessed using the State-Trait Operation Anxiety (STOA) and the Amsterdam Preoperative Anxiety and Information Scale (APAIS) questionnaires. Stress and pain will be measured using the Numeric Rating Scale (NRS) from 0 to 10. A baseline assessment of simulator sickness will be performed using the Simulator Sickness Questionnaire (SSQ), which evaluates three symptom groups: nausea, oculomotor discomfort, and disorientation.

Following the questionnaires, patients will undergo EEG monitoring using the BIS device (Bispectral Index Monitor). The BIS is a medical monitoring device widely used in anesthesiology to measure anesthesia depth based on EEG data. Different mental states are associated with specific EEG frequency bands (alpha, beta, gamma, delta, and theta), and EEG is a well-established method for evaluating emotions. Alpha waves are linked to increased relaxation and reduced sympathetic arousal, and enhancing alpha waves in neurofeedback therapy has been shown to reduce anxiety. Beta waves are often associated with motor tasks and cognitive processing, and studies have also shown that increased beta activity correlates with higher anxiety levels. Anxiety affects beta activity by shifting power from lower to higher frequencies. All this suggests that a decrease in alpha-beta ratios (ABR) and low-high beta ratios (BR) may indicate the presence of stress and anxiety. EEG monitoring will continue until the first postoperative hour. Continuous EEG recording allows intraoperative and postoperative EEG patterns to be correlated with anxiety scores and postoperative pain.

During the preoperative process, all patients will be monitored for blood pressure, respiratory rate, oxygen saturation, and heart rate. These measurements will be used to objectively document the effects of sympathetic nervous system activation due to anxiety.

The control group will receive routine clinical care, while the intervention group will undergo a 20-minute VR session. During the session, patients will watch videos of natural landscapes and listen to calming music and nature sounds through headphones to promote relaxation. If any discomfort occurs, the session will be immediately stopped. At the end of the VR session, the SSQ will be repeated. Before entering the operating room, anxiety, stress, and pain levels will be assessed again.

During the first postoperative hour, anxiety, stress, pain, and patient satisfaction with the study procedure will be evaluated. Satisfaction with the study and the VR intervention will be measured using the NRS and a satisfaction questionnaire specific to the VR session. Patients will also be assessed for delirium using the Nursing Delirium Screening Scale (Nu-DESC). Throughout the entire process, all patients will be continuously monitored using EEG/BIS.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • Written informed consent
  • All consecutive patients undergoing elective, outpatient, or inpatient surgery
  • No communication difficulties (e.g., hearing impairment) and good command of the German language
  • No visual impairment
  • Planned extubation immediately after surgery

Exclusion Criteria

  • Patients undergoing emergency surgery
  • Patients with documented psychiatric disorders (e.g., bipolar disorder), confusion, or epilepsy
  • Individuals admitted due to a court or official order
  • Expected non-compliance with the study protocol
  • Expected admission to an intermediate care unit (IMC) or intensive care unit (ICU)
  • Patients receiving sedative or anxiolytic medication for premedication
  • Patients with pacemakers or defibrillators

Arms & Interventions

Virtual reality glasses

Experimental

Intervention: Virtual reality glasses (Device)

Control

No Intervention

Outcomes

Primary Outcomes

The change of anxiety

Time Frame: From date of randomization until the date of first documented progression, assessed up to 8 hours

The STOA evaluates anxiety on two levels: the long-term, personality-related tendency toward surgical anxiety (trait) and the current state of anxiety (state), with cognitive and affective components. The STOA-State scale includes 10 items rated on a 4-point scale from 0 ("Not at all") to 3 ("Very much"), yielding a total score of 0-30. The STOA-Trait scale includes 20 items rated from 0 ("Almost never") to 3 ("Almost always"), with a total score of 0-60.

Secondary Outcomes

  • Change of preoperative stress and pain(From date of randomization until the date of first documented progression, assessed up to 8 hours)
  • Delirium incidence in the recovery room(From date of randomization until the date of first documented progression, assessed up to 8 hours)

Investigators

Sponsor
Vera Guttenthaler
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Vera Guttenthaler

Clinical Study Coordinator

University of Bonn

Study Sites (1)

Loading locations...

Similar Trials